Why Choose EverydayMeds For Your Complete Wegovy Journey
Can You Start Wegovy At 1.7mg Without Prior Escalation?
The question of whether you can start Wegovy at 1.7mg requires understanding the mandatory dose escalation protocol. According to MHRA licensing requirements, patients cannot skip directly to 1.7mg without progressing through the lower doses first. This prescription-only medicine follows a structured 16-week escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), then 1.7mg (weeks 13-16). The graduated approach minimises gastrointestinal side effects whilst allowing your body to adapt to semaglutide's appetite-suppressing effects.
At EverydayMeds, we maintain complete stock of all five Wegovy doses specifically to support this escalation journey. Our GPhC-registered pharmacy (#9012878) ensures you never face treatment interruptions due to dose unavailability. Whether you're currently at 1mg planning your progression or returning to treatment after a break, our clinical team can guide you to the appropriate starting point based on your medical history and recent Wegovy exposure.
Wegovy 1.7mg Pricing And Bundle Options For Seamless Progression
Our Wegovy 1.7mg single pen costs £139.99, with returning customers using code DOSE25 at checkout. For patients planning their transition to maintenance, our Elevate Duo bundle provides both 1.7mg and 2.4mg pens for £369.99, covering weeks 13-20 of treatment. This eliminates the need for separate orders and ensures uninterrupted supply as you progress to your maintenance dose. New customers receive even greater value with code FIRST40, whilst our Consistency 1.7mg bundle offers two 1.7mg pens for £309.99 for patients requiring extended time at this dose level.
The strategic advantage of choosing EverydayMeds becomes clear when planning your complete Wegovy journey. Rather than switching between pharmacies or facing stock shortages, our comprehensive inventory means one clinical assessment covers your entire treatment pathway. From initial 0.25mg starter doses at £79.99 through to maintenance 2.4mg supply at £209.99, we've structured our pricing to support long-term treatment success without premium pricing for higher doses.
Clinical Evidence Supporting Wegovy's Progressive Dosing Protocol
The requirement to progress through each dose before reaching 1.7mg stems from robust clinical evidence from the STEP trial programme. Wilding et al. (NEJM, 2021) demonstrated that patients following the complete escalation protocol achieved optimal weight management outcomes whilst minimising treatment discontinuation. In clinical trials, patients taking Wegovy alongside diet and exercise achieved average weight reductions of approximately 15% when following the full dose escalation schedule.
The STEP studies specifically evaluated this graduated approach, showing that patients who completed the escalation to 1.7mg and beyond experienced sustained appetite reduction and enhanced satiety. Attempting to bypass earlier doses may compromise both tolerability and effectiveness, explaining why prescribers require evidence of successful progression through lower doses before approving 1.7mg prescriptions.
Understanding How Wegovy Works At The 1.7mg Dose Level
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to regulate appetite and food intake. At the 1.7mg dose, semaglutide concentration reaches levels that significantly impact appetite centres in the brain, promoting enhanced satiety after smaller meals and reducing cravings between meals. The once-weekly injection maintains steady semaglutide levels, providing consistent appetite regulation throughout the seven-day dosing interval. This mechanism explains why dose escalation is essential - your GLP-1 receptors require gradual adaptation to prevent overwhelming gastrointestinal responses. By week 13 when 1.7mg becomes appropriate, most patients have developed tolerance to lower doses whilst maintaining therapeutic appetite suppression effects.
Streamlined Ordering Process For Wegovy 1.7mg Assessment
Ordering Wegovy 1.7mg through EverydayMeds begins with our 3-minute online clinical assessment, designed to verify your dose escalation history and current treatment status. Our UK-registered prescribers review applications within 3 working days (or 24 hours with express service), specifically evaluating your progression through previous Wegovy doses and any tolerance considerations. Once approved, your 1.7mg pen ships via next-day delivery using cold-chain transport to maintain the 2-8°C temperature requirements throughout transit. Our packaging includes gel packs and temperature monitors to ensure your prescription-only medicine arrives in optimal condition. The entire process from assessment to delivery typically completes within 4-5 days, or 2-3 days with express prescriber review for patients requiring urgent dose progression.
Storage And Practical Considerations For Wegovy 1.7mg Pens
Your Wegovy 1.7mg pen requires refrigerated storage at 2-8°C before first use, though it can tolerate room temperature below 30°C for up to 6 weeks once removed from the fridge. Each FlexTouch pen contains four doses of 0.425mg, delivering exactly 1.7mg per weekly injection for your four-week supply period. The pen's dose escalation design means the same injection technique used for lower doses applies to 1.7mg, maintaining consistency in your weekly routine. Proper storage becomes particularly important at this higher dose level, as temperature excursions can affect semaglutide potency and potentially reduce appetite suppression effectiveness. Always inspect your pen before injection, ensuring the solution appears clear and colourless without particles or cloudiness that might indicate temperature damage.
Why Complete Dose Availability Matters For Long-Term Wegovy Success
The unique advantage of choosing a pharmacy with complete Wegovy dose availability becomes apparent when considering long-term treatment outcomes. Patients who experience supply interruptions or forced dose reductions due to pharmacy stock limitations often struggle to regain momentum in their weight management journey. At EverydayMeds, our commitment to stocking all five Wegovy doses means your progression from 1mg to 1.7mg to maintenance 2.4mg occurs seamlessly without treatment gaps. This continuity proves essential because weight management represents a long-term commitment requiring consistent pharmaceutical support.
Clinical evidence suggests that treatment interruptions can necessitate dose re-escalation, effectively resetting your progress and extending time to maintenance levels. Our comprehensive inventory eliminates this risk, whilst our bundle options like the Elevate Duo specifically address the transition periods most vulnerable to supply disruptions. Patients appreciate knowing their pharmacy partner supports their complete journey rather than requiring transfers between providers as doses increase.
Secure Your Wegovy 1.7mg Supply And Plan Your Maintenance Transition
Ready to progress to Wegovy 1.7mg or planning your maintenance transition? Our clinical team at EverydayMeds can assess your dose escalation history and recommend the most appropriate next steps for your treatment journey. Returning customers should use code DOSE25 at checkout, whilst new patients benefit from code FIRST40 for optimal pricing on their first order. Visit our complete Wegovy collection at https://everydaymeds.co.uk/collections/wegovy to explore all dose options and bundle configurations tailored to your treatment stage. Remember that Wegovy works most effectively alongside a reduced-calorie diet and increased physical activity, with our prescriber guidance supporting your complete weight management strategy. Choose EverydayMeds for assured dose availability throughout your Wegovy journey, backed by our GPhC registration (#9012878) and commitment to seamless prescription delivery nationwide.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
